Lanova Medicines Limited

This study tests a new combination of drugs (LM-108 and toripalimab) against standard chemotherapy for people with advanced stomach cancer that has gotten worse after first treatment. About 400 adults with a specific marker (CCR8-positive) will be randomly assigned to receive eit…

This study tests a new drug called LM-24C5 combined with other cancer treatments for people with advanced solid tumors that have a specific protein (CEACAM5). About 130 adults aged 18-80 whose cancer has returned or not responded to standard care will participate. The goal is to …

This early-phase trial is testing an experimental drug called LM-350 in about 80 people with advanced solid tumors that have not responded to standard treatments. The study has two parts: first, to find a safe dose and check for side effects; second, to see if the drug can shrink…

This study is testing an experimental drug called LM-2417, given alone or with other cancer drugs, in people with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety, find the best dose, and see early signs of tumor shrinkage. …

This early-phase trial is testing a new drug called LM-168, alone or with the immunotherapy toripalimab, in 87 adults with advanced solid tumours that have not responded to standard treatments. The study first checks safety and the right dose, then looks for signs that the tumour…

This early-phase trial is testing an experimental drug called LM-24C5 in about 49 people with advanced solid tumors that have not responded to standard treatments. The main goals are to check the drug's safety, find the best dose, and see if it shows any signs of shrinking tumors…